glp-1 santa ana Hub: Support, Community, and Weight Loss Ana Reisdorf, MS, RD -
Description
The percentage of adults who report taking this class of medicine specifically for weight loss has increased to 12.4%, compared with 5.8% in February 2024 when Gallup first measured it
Exhibit 247 of our 2025 pharmacy/PBM report highlights 18 brand-name drugs for which manufacturers lowered the list prices of marketed products
[PubMed] Wilding JPH, Batterham RL, Calanna S, et al
Medication may be prescribed by a licensed provider when clinically appropriate and dispensed by a compounding pharmacy
2017 Feb;92(2):251-265
CMS has not extended Part D coverage to the obesity indication for tirzepatide
